Olema Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $364 | $0 |
Gross Profit | -128 | 182 | -95 | |
EBITDA | -47,864 | -34,745 | -36,652 | -37,526 |
EBIT | -34,873 | -36,768 | -37,621 | |
Net Income | -43,784 | -30,389 | -33,567 | -34,555 |
Net Change In Cash | 0 | 0 | 364 | 0 |
Free Cash Flow | -29,883 | -43,979 | -26,284 | -26,857 |
Cash | 52,473 | 50,640 | 139,480 | 35,888 |
Basic Shares | 85,497 | 85,426 | 58,743 | 57,262 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -393 | -377 | -1,658 | -1,663 |
EBITDA | -129,081 | -104,584 | -106,631 | -69,433 |
EBIT | -129,474 | -104,961 | -106,988 | -71,096 |
Net Income | -129,474 | -96,655 | -102,586 | -70,886 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | 9,890 | -324,737 | ||
Free Cash Flow | -104,510 | -83,727 | -82,428 | -52,265 |
Cash | 139,480 | 68,539 | 23,702 | 287,250 |
Basic Shares | 58,743 | 45,247 | 39,995 | 39,524 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.51 |
2025-03-31 | -$0.36 |
2024-12-31 | -$0.51 |
